[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.239.150.57. Please contact the publisher to request reinstatement.
Views 434
Citations 0
Comment & Response
February 2017

Validation of IDSA/ATS Algorithm for Duration of Pneumonia Therapy

Author Affiliations
  • 1Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen, St Gallen, Switzerland
  • 2Division of Infectious Diseases & Infection Control Program Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland
JAMA Intern Med. 2017;177(2):283-284. doi:10.1001/jamainternmed.2016.8574

To the Editor The randomized clinical trial (RCT) by Uranga et al1 in a recent issue of JAMA Internal Medicine aimed to validate the algorithm on antibiotic duration for community-acquired pneumonia (CAP) recommended by the 2007 guidelines.2 We congratulate Uranga et al on this study. It examines a timely and important issue: that limiting the duration of therapy is an understudied and underused aspect of antimicrobial stewardship. However, we have some concerns about the study’s design and conduct.

×